These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 7719153)
1. Effect of Pseudomonas aeruginosa on interleukin-8 release from human phagocytes. König B; Ceska M; König W Int Arch Allergy Immunol; 1995 Apr; 106(4):357-65. PubMed ID: 7719153 [TBL] [Abstract][Full Text] [Related]
2. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis. Pedersen SS APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of polymorphonuclear leukocyte chemotaxis by the mucoid exopolysaccharide of Pseudomonas aeruginosa. Stiver HG; Zachidniak K; Speert DP Clin Invest Med; 1988 Aug; 11(4):247-52. PubMed ID: 2971496 [TBL] [Abstract][Full Text] [Related]
4. Effects of mucoid and non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients on inflammatory mediator release from human polymorphonuclear granulocytes and rat mast cells. Friedl P; König B; König W Immunology; 1992 May; 76(1):86-94. PubMed ID: 1321094 [TBL] [Abstract][Full Text] [Related]
5. Functional role of mucoid exopolysaccharide (alginate) in antibiotic-induced and polymorphonuclear leukocyte-mediated killing of Pseudomonas aeruginosa. Bayer AS; Speert DP; Park S; Tu J; Witt M; Nast CC; Norman DC Infect Immun; 1991 Jan; 59(1):302-8. PubMed ID: 1898898 [TBL] [Abstract][Full Text] [Related]
6. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313 [TBL] [Abstract][Full Text] [Related]
7. Role of haemolytic and non-haemolytic phospholipase C from Pseudomonas aeruginosa in interleukin-8 release from human monocytes. König B; Vasil ML; König W J Med Microbiol; 1997 Jun; 46(6):471-8. PubMed ID: 9350199 [TBL] [Abstract][Full Text] [Related]
8. Alginate may accumulate in cystic fibrosis lung because the enzymatic and free radical capacities of phagocytic cells are inadequate for its degradation. Simpson JA; Smith SE; Dean RT Biochem Mol Biol Int; 1993 Aug; 30(6):1021-34. PubMed ID: 8220249 [TBL] [Abstract][Full Text] [Related]
9. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571 [TBL] [Abstract][Full Text] [Related]
10. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway. Fick RB; Sonoda F; Hornick DB Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541 [TBL] [Abstract][Full Text] [Related]
11. Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria. König B; Friedl P; Pedersen SS; König W Int Arch Allergy Immunol; 1992; 99(1):98-106. PubMed ID: 1336422 [TBL] [Abstract][Full Text] [Related]
12. New approaches to Pseudomonas aeruginosa lower respiratory tract infections. Matsumoto K Verh K Acad Geneeskd Belg; 1995; 57(2):109-22. PubMed ID: 7571853 [TBL] [Abstract][Full Text] [Related]
13. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses. Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330 [TBL] [Abstract][Full Text] [Related]
14. The transcriptional regulator AlgR controls cyanide production in Pseudomonas aeruginosa. Carterson AJ; Morici LA; Jackson DW; Frisk A; Lizewski SE; Jupiter R; Simpson K; Kunz DA; Davis SH; Schurr JR; Hassett DJ; Schurr MJ J Bacteriol; 2004 Oct; 186(20):6837-44. PubMed ID: 15466037 [TBL] [Abstract][Full Text] [Related]
15. Suppression of lymphocyte and neutrophil functions by Pseudomonas aeruginosa mucoid exopolysaccharide (alginate): reversal by physicochemical, alginase, and specific monoclonal antibody treatments. Mai GT; Seow WK; Pier GB; McCormack JG; Thong YH Infect Immun; 1993 Feb; 61(2):559-64. PubMed ID: 8423085 [TBL] [Abstract][Full Text] [Related]
16. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes. Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966 [TBL] [Abstract][Full Text] [Related]
17. Nonmucoid conversion of mucoid Pseudomonas aeruginosa induced by sulfate-stimulated growth. Min KB; Lee KM; Oh YT; Yoon SS FEMS Microbiol Lett; 2014 Nov; 360(2):157-66. PubMed ID: 25227776 [TBL] [Abstract][Full Text] [Related]
18. Effects of alginase on the natural history and antibiotic therapy of experimental endocarditis caused by mucoid Pseudomonas aeruginosa. Bayer AS; Park S; Ramos MC; Nast CC; Eftekhar F; Schiller NL Infect Immun; 1992 Oct; 60(10):3979-85. PubMed ID: 1398909 [TBL] [Abstract][Full Text] [Related]
19. Polysaccharides serve as scaffold of biofilms formed by mucoid Pseudomonas aeruginosa. Yang L; Hengzhuang W; Wu H; Damkiaer S; Jochumsen N; Song Z; Givskov M; Høiby N; Molin S FEMS Immunol Med Microbiol; 2012 Jul; 65(2):366-76. PubMed ID: 22309122 [TBL] [Abstract][Full Text] [Related]
20. The roles of biofilm matrix polysaccharide Psl in mucoid Pseudomonas aeruginosa biofilms. Ma L; Wang S; Wang D; Parsek MR; Wozniak DJ FEMS Immunol Med Microbiol; 2012 Jul; 65(2):377-80. PubMed ID: 22309106 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]